A comprehensive retrospective study published in the Graefe's Archive for Clinical and Experimental Ophthalmology ...

Recently published study aimed to determine the optimal end-tidal sevoflurane concentration for safely measuring intraocular pressure (IOP) in pediatric patients aged 1–12 months and 12–36 ...

More information: Yu Cheng et al, Displacement-pressure biparametrically regulated softness sensory system for intraocular pressure monitoring, National Science Review (2024). DOI: 10.1093/nsr/nwae050 ...

Glaucoma stands as a preventable purveyor of blindness, particularly among Black and Hispanic communities. Genetic predispositions, socioeconomic disparities, and systemic barriers make glaucoma's ...

Ocular Therapeutix's Phase 1 HELIOS study unveils Axpaxli's efficacy in treating non-proliferative diabetic retinopathy.

Microscopic in size, the company’s products Aliso Viejo-based Glaukos, dubbed the iStent, are often used in conjunction with ...

Qlaris Bio, Inc. (“Qlaris”), a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced that it has closed a $24 million Series B financing round ...

Discover the groundbreaking patent by EyePoint Pharmaceuticals Inc for treating ocular conditions with multi-specific compounds targeting phosphatase and receptor tyrosine kinase agonists.

During this appointment, your ophthalmologist also will measure your eye to properly fit your intraocular lens ... your eyes or otherwise putting pressure on them. Wear sunglasses when outdoors.

In 2024, the global contact lenses market is estimated to be valued at US$ 10,035.9 million, with projections indicating a growth to US$ 16,256.8 million by 2034. Over the forecast period, the demand ...

Significant DRSS improvement with no worsening observed. Positive Phase 2 data for Paxtrava also disclosed, showing substantial reduction in intraocular pressure.

Discover the groundbreaking patent by EyePoint Pharmaceuticals for treating ocular conditions with multi-specific compounds targeting phosphatase and receptor tyrosine kinase agonists. Treat diabetic ...